Blue light-triggered optogenetic system for treating uveal melanoma
- 6 December 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (10), 2118-2124
- https://doi.org/10.1038/s41388-019-1119-5
Abstract
Uveal melanoma is the most common intraocular primary malignancy in adults and has been considered a fatal disease for decades. Optogenetics is an emerging technique that can control the activation of signaling components via irradiation with visible light. The clinical translation of optogenetics has been limited because of the need for surgical implantation of electrodes and relatively shallow tissue penetration. As visible light easily penetrates the eyes, we hypothesized that an optogenetics approach can be an effective treatment of uveal melanoma without surgery. In this study, we evaluated the feasibility of this strategy by using a genetically encoded optogenetic system based on reversible blue light-induced binding pairs between Fas-CIB1-EGFP and CRY2-mCherry-FADD. Subretinal injection of B16 cells was performed to create a uveal melanoma model. Plasmids pairs were co-transfected into B16 cells. We found that blue light irradiation dynamically controlled the translocation of FADD to Fas on the plasma membrane and induced the apoptosis of B16 cells transfected with the optogenetic nanosystem in vitro. Moreover, the blue light-controlled optogenetic nanosystem suppressed the growth of uveal melanoma in vivo by inducing apoptosis. These results suggest that light-controlled optogenetic therapy can be used as a potential novel therapeutic strategy for uveal melanoma.Keywords
Funding Information
- Natural Science Foundation of Tianjin City (18JCQNJC11300)
This publication has 36 references indexed in Scilit:
- Combined PKC and MEK inhibition for treating metastatic uveal melanomaOncogene, 2014
- Optical control of mammalian endogenous transcription and epigenetic statesNature, 2013
- MicroRNA-124a Is Epigenetically Regulated and Acts as a Tumor Suppressor by Controlling Multiple Targets in Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2013
- CLINICAL AND HISTOPATHOLOGIC FINDINGS AFTER PHOTODYNAMIC THERAPY OF CHOROIDAL MELANOMARetina, 2012
- Impact of near-infrared radiation in dermatologyWorld Journal of Dermatology, 2012
- Treatment Selection for Uveal MelanomaGlaucoma Surgery, 2011
- Rapid blue-light–mediated induction of protein interactions in living cellsNature Methods, 2010
- Ectopic Expression of Multiple Microbial Rhodopsins Restores ON and OFF Light Responses in Retinas with Photoreceptor DegenerationJournal of Neuroscience, 2009
- Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanomaOncology Reports, 2009
- Cell damage in near-infrared multimode optical traps as a result of multiphoton absorptionOptics Letters, 1996